Thermo Fisher Scientific Inc. (TN8.DE)
EUR 505.8
(0.08%)
EUR 505.8
(0.08%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 7.61 Billion | 8.55 Billion | 8.19 Billion | 6.77 Billion | 4.43 Billion | 3.97 Billion |
| Net Income | 5.43 Billion | 6.49 Billion | 6.79 Billion | 5.21 Billion | 3.29 Billion | 2.57 Billion |
| Depreciation & Amortization | 3.08 Billion | 3.15 Billion | 2.28 Billion | 1.9 Billion | 2.02 Billion | 1.98 Billion |
| Deferred income taxes | -1.17 Billion | -929.68 Million | -569.22 Million | -451.14 Million | -269.04 Million | -331.54 Million |
| Stock-based compensation | 278 Million | 307 Million | 230 Million | 196 Million | - | - |
| Change in working capital | -486.52 Million | -980.14 Million | -1.36 Billion | -322.83 Million | -592.42 Million | -498.62 Million |
| Other non-cash items | 6.88 Billion | 7.69 Billion | 6.3 Billion | 5.66 Billion | 4.39 Billion | 4.64 Billion |
| Investing Cash Flow | -4.65 Billion | -2.01 Billion | -19.29 Billion | -1.23 Billion | -1.32 Billion | -1.09 Billion |
| Investments in PPE | -1.33 Billion | -2.09 Billion | -2.21 Billion | -1.2 Billion | -824.94 Million | -663.08 Million |
| Acquisitions | -3.23 Billion | -14.01 Million | -17.04 Billion | -24.51 Million | -604.9 Million | -425.14 Million |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | 70 Million | 15 Million | 8 Million | - | - | - |
| Other Investing Activities | -81.54 Million | 92.5 Million | -29.91 Million | -4.9 Million | 105.12 Million | -7.87 Million |
| Financing Cash Flow | -3.28 Billion | -2.62 Billion | 5.78 Billion | 783.78 Million | -2.77 Billion | -1.95 Billion |
| Debt repayment | -140.43 Million | -611.07 Million | -7.83 Billion | -2.24 Billion | -1.25 Billion | -1.36 Billion |
| Dividends payments | -473.84 Million | -425.13 Million | -347.51 Million | -275.42 Million | -264.58 Million | -232.69 Million |
| Common Stock Repurchased | -2.71 Billion | -2.8 Billion | -1.75 Billion | -1.22 Billion | -1.33 Billion | -437.38 Million |
| Common Stock Issuance | - | - | 137.24 Million | 160.18 Million | 136.3 Million | 118.96 Million |
| Other Financing Activities | 50.73 Million | -8.4 Million | -80.06 Million | -122.59 Million | -61.46 Million | -44.61 Million |
| Accounts receivables | -38.95 Million | -401.77 Million | -179.47 Million | -1.06 Billion | -200.44 Million | -320.16 Million |
| Accounts payables | -453 Million | 605.46 Million | 421.41 Million | 48.22 Million | 236.97 Million | 175.82 Million |
| Inventory | 541.79 Million | -770.84 Million | -936.97 Million | -415.18 Million | -408.01 Million | -283.42 Million |
| Other working capital | -536.35 Million | -412.98 Million | -666.87 Million | 1.1 Billion | -220.93 Million | -70.85 Million |
| Cash at beginning of period | 7.97 Billion | 3.95 Billion | 8.44 Billion | 2.15 Billion | 1.85 Billion | 1.13 Billion |
| Cash at end of period | 7.32 Billion | 7.97 Billion | 3.95 Billion | 8.44 Billion | 2.15 Billion | 1.85 Billion |
| Capital Expenditure | -1.33 Billion | -2.09 Billion | -2.21 Billion | -1.2 Billion | -824.94 Million | -663.08 Million |
| Effect of forex changes on cash | -82 Million | -139 Million | 194 Million | 176 Million | - | - |
| Net cash flow / Change in cash | -652.42 Million | 4.02 Billion | -4.49 Billion | 6.29 Billion | 305.75 Million | 718.4 Million |
| Free Cash Flow | 6.27 Billion | 6.45 Billion | 5.97 Billion | 5.56 Billion | 3.6 Billion | 3.31 Billion |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 1.55 Billion | 1.22 Billion | 1.47 Billion | 5.43 Billion | 1.62 Billion | 1.24 Billion |
| Depreciation & Amortization | 791 Million | 774.79 Million | 760.14 Million | 3.08 Billion | 806.93 Million | 783.87 Million |
| Deferred income taxes | -354 Million | -234.47 Million | -606.12 Million | -1.17 Billion | -286.63 Million | -166.85 Million |
| Stock-based compensation | 84 Million | 70 Million | 61 Million | 278 Million | 67 Million | 74 Million |
| Change in working capital | -216 Million | -729.37 Million | 1.56 Billion | -486.52 Million | -8.51 Million | -658.26 Million |
| Other non-cash items | 101 Million | 1.66 Billion | 1.7 Billion | 6.88 Billion | 1.76 Billion | 1.77 Billion |
| Investing Cash Flow | -253 Million | -1.88 Billion | -340.65 Million | -4.65 Billion | -1.11 Billion | -406.14 Million |
| Investments in PPE | -301 Million | -321.59 Million | -366.93 Million | -1.33 Billion | -314.06 Million | -260.37 Million |
| Acquisitions | 14.93 Million | 3.7 Million | 9.96 Million | -3.23 Billion | -797.47 Million | -39.42 Million |
| Investment purchases | -20 Million | -1.62 Billion | - | - | - | - |
| Sales/Maturities of investments | 47 Million | 64 Million | - | 70 Million | - | - |
| Other Investing Activities | 5 Million | 65.8 Million | 16.3 Million | -81.54 Million | -5.67 Million | -106.34 Million |
| Financing Cash Flow | -115 Million | -1.68 Billion | -1.29 Billion | -3.28 Billion | 1.75 Billion | -1.33 Billion |
| Debt repayment | -1 Million | -1.11 Billion | -1.18 Billion | -140.43 Million | -1.86 Billion | -1.21 Billion |
| Dividends payments | -149 Million | -125.11 Million | -123.21 Million | -473.84 Million | -127.7 Million | -123.76 Million |
| Common Stock Repurchased | - | -2.78 Billion | - | -2.71 Billion | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | 35 Million | 101.94 Million | 12.68 Million | 50.73 Million | 17.02 Million | 3.66 Million |
| Accounts receivables | - | - | - | -38.95 Million | - | - |
| Accounts payables | - | - | - | -453 Million | - | - |
| Inventory | - | - | - | 541.79 Million | - | - |
| Other working capital | -216 Million | - | - | -536.35 Million | - | - |
| Cash at beginning of period | 5.51 Billion | 7.32 Billion | 5.82 Billion | 7.97 Billion | 2.88 Billion | 3.22 Billion |
| Cash at end of period | 7.09 Billion | 5.1 Billion | 7.32 Billion | 7.32 Billion | 5.82 Billion | 2.88 Billion |
| Capital Expenditure | -301 Million | -321.59 Million | -366.93 Million | -1.33 Billion | -314.06 Million | -260.37 Million |
| Effect of forex changes on cash | -15 Million | 22 Million | 10 Million | -82 Million | -73 Million | 12 Million |
| Net cash flow / Change in cash | 1.57 Billion | -2.22 Billion | 1.49 Billion | -652.42 Million | 2.94 Billion | -338.6 Million |
| Free Cash Flow | 1.65 Billion | 837.81 Million | 3 Billion | 6.27 Billion | 1.96 Billion | 1.15 Billion |
002545
300188
002599
000852
SIXD
ARCH